HawkInsight

  • Contact Us
  • App
  • English

Acadia Pharmaceuticals will replace Independent Bank Group in S&P SmallCap 600

 Acadia Pharmaceuticals (NASDAQ:ACAD) will replace Independent Bank Group (NASDAQ:IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState (SSB) is acquiring Independent Bank Group (IBTX) in a deal expected to close soon pending final conditions.

Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.

NewFlashHawk Insight
More